429 related articles for article (PubMed ID: 29722796)
1. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
[TBL] [Abstract][Full Text] [Related]
2. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
[TBL] [Abstract][Full Text] [Related]
3. Randomized Controlled Comparison of Optimal Medical Therapy with Percutaneous Recanalization of Chronic Total Occlusion (COMET-CTO).
Juricic SA; Tesic MB; Galassi AR; Petrovic ON; Dobric MR; Orlic DN; Vukcevic VD; Stankovic GR; Aleksandric SB; Tomasevic MV; Nedeljkovic MA; Beleslin BD; Jelic DD; Ostojic MC; Stojkovic SM
Int Heart J; 2021; 62(1):16-22. PubMed ID: 33518655
[TBL] [Abstract][Full Text] [Related]
4. Optimal medical therapy may be a better initial strategy in patients with chronic total occlusion of a single coronary artery.
Hwang JW; Yang JH; Choi SH; Hwang JK; Jang WJ; Hahn JY; Song YB; Choi JH; Lee SH; Gwon HC
Int J Cardiol; 2016 May; 210():56-62. PubMed ID: 26930638
[TBL] [Abstract][Full Text] [Related]
5. Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status.
Peri-Okonny PA; Spertus JA; Grantham JA; Gosch K; Kirtane A; Sapontis J; Lombardi W; Karmpaliotis D; Moses J; Nicholson W; Salisbury AC
J Am Heart Assoc; 2019 Apr; 8(7):e011629. PubMed ID: 30922149
[TBL] [Abstract][Full Text] [Related]
6. International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial - rationale and design.
Råmunddal T; Holck EN; Karim S; Eftekhari A; Escaned J; Ioanes D; Walsh S; Spratt J; Veien K; Jensen LO; Tilsted HH; Terkelsen CJ; Havndrup O; Olsen NT; Kajander OA; Faurie B; Lanematt P; Jakobsen L; Christiansen EH
Am Heart J; 2023 Mar; 257():41-50. PubMed ID: 36423733
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
8. Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO).
Werner GS; Hildick-Smith D; Martin Yuste V; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; Di Mario C; Teruel L; Bufe A; Lauer B; Galassi AR; Louvard Y
EuroIntervention; 2023 Sep; 19(7):571-579. PubMed ID: 37482940
[TBL] [Abstract][Full Text] [Related]
9. Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.
Hirai T; Qintar M; Grantham JA; Sapontis J; Cohen DJ; Lombardi W; Karmpaliotis D; Moses J; Nicholson WJ; Nugent K; Gosch KL; Spertus JA; Salisbury AC
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005287. PubMed ID: 31185735
[TBL] [Abstract][Full Text] [Related]
10. Association of Successful Percutaneous Revascularization of Chronic Total Occlusions With Quality of Life: A Systematic Review and Meta-Analysis.
Kucukseymen S; Iannaccone M; Grantham JA; Sapontis J; Juricic S; Ciardetti N; Mattesini A; Stojkovic S; Strauss BH; Wijeysundera HC; Werner GS; D'Ascenzo F; Di Mario C
JAMA Netw Open; 2023 Jul; 6(7):e2324522. PubMed ID: 37471086
[TBL] [Abstract][Full Text] [Related]
11. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
[TBL] [Abstract][Full Text] [Related]
12. Gender Differences in Long-Term Outcomes of Medical Therapy and Successful Percutaneous Coronary Intervention for Coronary Chronic Total Occlusions.
Guo L; Lv H; Zhong L; Wu J; Ding H; Xu J; Huang R
J Interv Cardiol; 2019; 2019():2017958. PubMed ID: 31772516
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina.
Hirai T; Grantham JA; Sapontis J; Cohen DJ; Marso SP; Lombardi W; Karmpaliotis D; Moses J; Nicholson WJ; Pershad A; Wyman RM; Spaedy A; Cook S; Doshi P; Federici R; Nugent K; Gosch KL; Spertus JA; Salisbury AC
Circ Cardiovasc Interv; 2019 Mar; 12(3):e007558. PubMed ID: 30871356
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO).
Juricic SA; Stojkovic SM; Galassi AR; Stankovic GR; Orlic DN; Vukcevic VD; Milasinovic DG; Aleksandric SB; Tomasevic MV; Dobric MR; Nedeljkovic MA; Beleslin BD; Dikic MP; Banovic MD; Ostojic MC; Tesic MB
Front Cardiovasc Med; 2022; 9():1014664. PubMed ID: 36698926
[TBL] [Abstract][Full Text] [Related]
17. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
18. Effect of PCI on quality of life in patients with stable coronary disease.
Weintraub WS; Spertus JA; Kolm P; Maron DJ; Zhang Z; Jurkovitz C; Zhang W; Hartigan PM; Lewis C; Veledar E; Bowen J; Dunbar SB; Deaton C; Kaufman S; O'Rourke RA; Goeree R; Barnett PG; Teo KK; Boden WE; ; Mancini GB
N Engl J Med; 2008 Aug; 359(7):677-87. PubMed ID: 18703470
[TBL] [Abstract][Full Text] [Related]
19. Long-term improvement of symptoms of angina pectoris after successful revascularization of coronary artery chronic total occlusions.
Miyashita H; Mansikkaniemi L; Sinisalo J; Stewart J; Laine P
Scand Cardiovasc J; 2023 Dec; 57(1):2161621. PubMed ID: 36587829
[No Abstract] [Full Text] [Related]
20. Midterm Angina-Related Quality of Life Benefits After Percutaneous Coronary Intervention of Chronic Total Occlusions.
Ybarra LF; Dautov R; Gibrat C; Dandona S; Rinfret S
Can J Cardiol; 2017 Dec; 33(12):1668-1674. PubMed ID: 29066329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
